Logo image of BYL.CA

BAYLIN TECHNOLOGIES INC (BYL.CA) Stock Fundamental Analysis

TSX:BYL - CA0728191051 - Common Stock

0.32 CAD
-0.02 (-5.88%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, BYL scores 2 out of 10 in our fundamental rating. BYL was compared to 13 industry peers in the Electronic Equipment, Instruments & Components industry. BYL has a bad profitability rating. Also its financial health evaluation is rather negative. BYL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BYL has reported negative net income.
In the past year BYL had a positive cash flow from operations.
BYL had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BYL reported negative operating cash flow in multiple years.
BYL.CA Yearly Net Income VS EBIT VS OCF VS FCFBYL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

BYL has a Return On Assets (-10.15%) which is in line with its industry peers.
Industry RankSector Rank
ROA -10.15%
ROE N/A
ROIC N/A
ROA(3y)-20.62%
ROA(5y)-29.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYL.CA Yearly ROA, ROE, ROICBYL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K 20K 30K

1.3 Margins

BYL has a better Gross Margin (43.27%) than 61.54% of its industry peers.
In the last couple of years the Gross Margin of BYL has grown nicely.
BYL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.78%
GM growth 5Y2.81%
BYL.CA Yearly Profit, Operating, Gross MarginsBYL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

BYL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BYL has been increased compared to 1 year ago.
BYL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BYL has a worse debt to assets ratio.
BYL.CA Yearly Shares OutstandingBYL.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BYL.CA Yearly Total Debt VS Total AssetsBYL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -4.51, we must say that BYL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BYL (-4.51) is worse than 76.92% of its industry peers.
BYL has a debt to FCF ratio of 5.14. This is a neutral value as BYL would need 5.14 years to pay back of all of its debts.
BYL's Debt to FCF ratio of 5.14 is fine compared to the rest of the industry. BYL outperforms 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.14
Altman-Z -4.51
ROIC/WACCN/A
WACC9.11%
BYL.CA Yearly LT Debt VS Equity VS FCFBYL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

BYL has a Current Ratio of 0.84. This is a bad value and indicates that BYL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BYL (0.84) is worse than 84.62% of its industry peers.
A Quick Ratio of 0.51 indicates that BYL may have some problems paying its short term obligations.
BYL has a worse Quick ratio (0.51) than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.51
BYL.CA Yearly Current Assets VS Current LiabilitesBYL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

BYL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.93%, which is quite impressive.
Looking at the last year, BYL shows a very negative growth in Revenue. The Revenue has decreased by -40.27% in the last year.
BYL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.42% yearly.
EPS 1Y (TTM)91.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-40.27%
Revenue growth 3Y-6.57%
Revenue growth 5Y-11.42%
Sales Q2Q%1.91%

3.2 Future

Based on estimates for the next years, BYL will show a very strong growth in Earnings Per Share. The EPS will grow by 22.47% on average per year.
The Revenue is expected to grow by 0.27% on average over the next years.
EPS Next Y0%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.9%
Revenue Next 2Y0.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BYL.CA Yearly Revenue VS EstimatesBYL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
BYL.CA Yearly EPS VS EstimatesBYL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BYL. In the last year negative earnings were reported.
Also next year BYL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYL.CA Price Earnings VS Forward Price EarningsBYL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BYL indicates a rather cheap valuation: BYL is cheaper than 84.62% of the companies listed in the same industry.
BYL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BYL is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.1
EV/EBITDA 35.12
BYL.CA Per share dataBYL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as BYL's earnings are expected to grow with 22.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BYL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAYLIN TECHNOLOGIES INC

TSX:BYL (8/29/2025, 7:00:00 PM)

0.32

-0.02 (-5.88%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners1.88%
Ins Owner ChangeN/A
Market Cap48.81M
Analysts76.67
Price Target0.38 (18.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.38%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-33.33%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)-2.4%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.59
P/FCF 8.1
P/OCF 7.97
P/B N/A
P/tB N/A
EV/EBITDA 35.12
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.04
FCFY12.35%
OCF(TTM)0.04
OCFY12.55%
SpS0.54
BVpS-0.06
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.15%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.27%
FCFM 7.28%
ROA(3y)-20.62%
ROA(5y)-29.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.78%
GM growth 5Y2.81%
F-Score4
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.14
Debt/EBITDA 17.09
Cap/Depr 3.9%
Cap/Sales 0.12%
Interest Coverage N/A
Cash Conversion 347.42%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.51
Altman-Z -4.51
F-Score4
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)11.25%
Cap/Depr(5y)21.99%
Cap/Sales(3y)0.89%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y0%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.27%
Revenue growth 3Y-6.57%
Revenue growth 5Y-11.42%
Sales Q2Q%1.91%
Revenue Next Year-3.9%
Revenue Next 2Y0.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year310.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y666.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y284.01%
OCF growth 3YN/A
OCF growth 5YN/A